Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Legal / IP
China’s Supreme Court Deals Blow to Sanofi’s Aubagio, Confirms Patent Cancellation
October 13, 2024
Company
Deals
Pfizer Partners with Quotient Therapeutics for Somatic Mutations Research in Cardiovascular and Renal Diseases
October 13, 2024
Company
Deals
Sackler-Owned Mundipharma Fails to Secure $1 Billion Valuation for China Unit
October 13, 2024
Company
Drug
Sinopharm and Ruidio Pharmaceutical Advance in Priority Review for Innovative Drugs and Vaccines
November 24, 2024
Company
Drug
Jiangsu Simcere and AnDiConBio’s Anti-Influenza Drug ADC189 Doses First Patient in Phase III Study
October 13, 2024
Company
Drug
Sino Biopharmaceutical’s Anlotinib-Penpulimab Combo Meets Milestone in Phase III HCC Study
October 13, 2024
Company
Deals
Leaderna Therapeutics Secures RMB 100 Million in Funding to Accelerate Nucleic Acid Drug Development
October 13, 2024
Company
Medical Device
Advancing Peripheral Artery Disease Care: Boston Scientific’s JETSTREAM Receives Marketing Nod in China
October 13, 2024
Policy / Regulatory
China’s New Medical Device Regulations: A Comprehensive Framework for Industry Growth and Safety
October 13, 2024
Company
Innovent Biologics Reports 46.3% YOY Revenue Growth and Expands Portfolio with New Approvals and NDAs
October 13, 2024
Company
Deals
Tigermed Partners with Beijing Government to Open North Headquarters, Expanding Collaboration in Biotech
October 13, 2024
Company
Luye Pharma Group’s 2024H1 Revenue and Net Profits Surge, Driven by Oncology and CNS Therapy Revenues
October 13, 2024
1
2
…
606
607
608
609
610
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?